planning to introduce IPV and the global status of bOPV registration Countries using and planning to introduce IPV May 2016 status report This slide deck provides a summary per country on the status of planning for the introduction of Inactivated Poliomyelitis Vaccine IPV ID: 576518
Download Presentation The PPT/PDF document "Countries using and" is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Slide1
Countries using and
planning to introduce IPV
and the global status of
bOPV
registrationSlide2
Countries using and planning to introduce IPVMay 2016 status report
This slide deck provides a summary per country on the status of planning for the introduction of Inactivated Poliomyelitis Vaccine (IPV).
It also includes a summary of the global status of national registration of bivalent Oral Polio Vaccine (
bOPV
), in preparation for the switch from trivalent OPV (
tOPV
) to
bOPV
.
Information here is updated monthly based on information shared by WHO and UNICEF Regional Offices. Please contact
polio2@who.int
with any questions or updates on this data.
Definitions
Formal decision
to introduce:
The country has documentation of its decision to introduce IPV which has been verified by the relevant WHO Regional Office, or for
Gavi
eligible countries, a complete application for IPV has been submitted to the
Gavi
Secretariat.
Tracking
these decisions and informal intents provide an indication of the global trend towards meeting the targets of the
Polio Eradication and Endgame Strategic Plan
.Slide3
Countries using IPV vaccine to date
and formal decision to introduce
Since January 2013, the following countries have introduced IPV: Kazakhstan, Peru & Singapore (July 2013); Micronesia (August 2013); Libya (April 2014); Albania & Panama (May 2014); Nepal & Tunisia (September 2014); Philippines (October 2014); China (December 2014); Comoros, Senegal & Serbia (January 2015); Colombia & Nigeria (February 2015); Bangladesh & Maldives (March 2015); DR Congo, DPR Korea & The Gambia (April 2015); Madagascar (May 2015); Cote d'Ivoire, Grenada, Kiribati, Morocco, St Vincent and the Grenadines & Sudan (June 2015); Bhutan, Cameroon, Niger, Pakistan, Philippines & Sri Lanka (July 2015); Benin, Chad, Papua New Guinea, The Former Yug. Rep. of Macedonia (August 2015); Afghanistan, CAR, Dominica, Guyana, Iran, Jamaica, Seychelles & Solomon Islands (September 2015); Bahamas, Lao People's Dem Rep, Nauru, Samoa (October 2015); Antigua and Barbuda, Botswana, Burundi, Cook Islands, Guinea, India, Mauritania, Mauritius, Mozambique, Namibia, Nicaragua, St Lucia, Suriname, Tuvalu, Vanuatu & Yemen (November 2015); Algeria, Belize, Cambodia, Dominical Rep, Ecuador, Ethiopia, Fiji, Gabon, Georgia, Honduras, Kenya, Myanmar, Paraguay, St Kitts & Nevis, S. Sudan, Thailand, Tonga & Trinidad & Tobago (December 2015); Cuba, El Salvador, Guatemala, Haiti, Iraq & Venezuela (Bolivian Rep of) (January 2016); Azerbaijan, Bolivia & Timor-Leste (February 2016); Chile & Mali (March 2016); Argentina, Congo, Djibouti, Lesotho, Sao Tome & P., Uganda (April 2016)
Data source: WHO/IVB Database, as of 03 May 2016
Map production Immunization Vaccines and Biologicals (IVB),
World Health Organization
Date of slide: 3 May 2016
The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. ©WHO 2016. All rights reserved.
Introduced to date*
(168 countries or 87%)
(20 countries or 10%)
Not available
Not applicable
Introduction delayed in 2017
Formal commitment to introduce in 2016
(6 countries or 3%)
* Including partial introduction in India Slide4
* Including partial introduction in India
Countries using IPV vaccine to date and introductions planned according to Gavi eligibility status
Data source: WHO/IVB Database, as of 03 May 2016
Map production Immunization Vaccines and Biologicals (IVB),
World Health Organization
Date of slide: 3 May 2016
The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. ©WHO 2016. All rights reserved.
Introduced to date*
(168 countries or 87%)
Gavi
countries with formal commitment to introduce in 2016-2017
(21 countries or 10%)
Non
Gavi
countries with formal commitment to introduce in 2016-2017
(5 countries or 3%)
Not available
Not applicable
Since January 2013, the following countries have introduced IPV: Kazakhstan, Peru & Singapore (July 2013); Micronesia (August 2013); Libya (April 2014); Albania & Panama (May 2014); Nepal & Tunisia (September 2014); Philippines (October 2014); China (December 2014); Comoros, Senegal & Serbia (January 2015); Colombia & Nigeria (February 2015); Bangladesh & Maldives (March 2015); DR Congo, DPR Korea & The Gambia (April 2015); Madagascar (May 2015); Cote d'Ivoire, Grenada, Kiribati, Morocco, St Vincent and the Grenadines & Sudan (June 2015); Bhutan, Cameroon, Niger, Pakistan, Philippines & Sri Lanka (July 2015); Benin, Chad, Papua New Guinea, The Former Yug. Rep. of Macedonia (August 2015); Afghanistan, CAR, Dominica, Guyana, Iran, Jamaica, Seychelles & Solomon Islands (September 2015); Bahamas, Lao People's Dem Rep, Nauru, Samoa (October 2015); Antigua and Barbuda, Botswana, Burundi, Cook Islands, Guinea, India, Mauritania, Mauritius, Mozambique, Namibia, Nicaragua, St Lucia, Suriname, Tuvalu, Vanuatu & Yemen (November 2015); Algeria, Belize, Cambodia, Dominical Rep, Ecuador, Ethiopia, Fiji, Gabon, Georgia, Honduras, Kenya, Myanmar, Paraguay, St Kitts & Nevis, S. Sudan, Thailand, Tonga & Trinidad & Tobago (December 2015); Cuba, El Salvador, Guatemala, Haiti, Iraq & Venezuela (Bolivian Rep of) (January 2016); Azerbaijan, Bolivia & Timor-Leste (February 2016); Chile & Mali (March 2016); Argentina, Congo, Djibouti, Lesotho, Sao Tome & P., Uganda (April 2016) Slide5
26 countries introducing IPV between 3 May 2016 and February 2017Tier
1 countries are countries with cVDPV2 transmission or cVDPV2
reported since 2000 & WPV endemic
countries
Tier
2 countries
are countries
with cVDPV 1/3 since 2000 or large /medium size countries with DTP3 coverage <80% in the past 3 years as
per WUENIC
Data source: WHO/IVB Database, as of 03 May 2016Map production Immunization Vaccines and Biologicals (IVB),World Health Organization
May – July
2016
2017
Armenia
Angola
Cabo Verde
Burkina Faso
Equatorial Guinea
Egypt
Guinea-Bissau
Eritrea
Indonesia
Ghana
Swaziland
Kyrgyzstan
Liberia
Malawi
Mongolia
Rep. of Moldova
Rwanda
Sierra Leone
Tajikistan
Togo
Turkmenistan
United Rep. of Tanzania
Uzbekistan
Viet Nam
Zambia
Zimbabwe
6
20
Legend
Tier 2 countriesSlide6
Tier 1 and 2 Countries using IPV vaccine to date
and formal decision to introduce
Tier 1 countries are countries with cVDPV2 transmission or cVDPV2 reported since 2000 & WPV endemic countries
Tier 2 countries are countries with
cVDPV
1/3 since 2000 or large /Medium size countries
with DTP3 coverage <80% in the past 3 years as per WUENIC
Since January 2013, the following Tier 1 and 2 countries have introduced IPV:The Philippines (October 2014), China (December 2014), Nigeria (February 2015), DR Congo (April 2015), Madagascar (May 2015), Cameroon, Niger and Pakistan (July 2015); Benin, Chad and Papua New Guinea (August 2015); Afghanistan and CAR (September 2015); Lao People's Democratic Republic (October 2015); Guinea, India, Mauritania, Mozambique, Somalia & Yemen (November 2015); Cambodia, Dominican Rep., Ethiopia, Gabon, Kenya, Myanmar & S. Sudan (December 2015); Haiti & Iraq (January 2016); Azerbaijan, Bolivia & Timor-Leste (February 2016); Mali (March 2016); Congo & Uganda (April 2016)
Data source: WHO/IVB Database, as of 03 May 2016,
based on 36 tier 1 & 2 countriesMap production Immunization Vaccines and Biologicals (IVB),World Health Organization
Date of slide: 3 May 2016
The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. ©WHO 2016. All rights reserved.Introduced to date* (34 countries or 94%)
(2 countries or 6%)
Formal commitment to introduce in 2016
Not applicable / not available / not Tier 1 or 2 countries
* Including partial introduction in India Slide7
Middle Income Countries using IPV vaccine to date
and formal decision to introduce
Since January 2013, the following MIC have introduced IPV:
Kazakhstan (July 2013); Peru (July 2013); Libya (March 2014); Albania (May 2014); Panama (July 2014); Tunisia (September 2014); Philippines (October 2014); China (December 2014); Senegal (January 2015); Serbia (January 2015); Colombia (February 2015); Maldives (March 2015) and Cote d'Ivoire, Kiribati, Morocco, St Vincent and the Grenadines & Sudan (June 2015); Bhutan, Cameroon, Pakistan & Sri Lanka (July 2015); Papua New Guinea & the former Yugoslav Rep. of Macedonia (August 2015); Dominica, Guyana, Iran, Jamaica & Solomon Islands (September 2015); Lao People's Democratic Rep & Samoa (October 2015); Botswana, India, Mauritania, Mauritius, Namibia, Nicaragua, St Lucia, Tuvalu , Vanuatu & Yemen (November 2015); Algeria, Belize, Dominican Rep, Ecuador, Fiji, Gabon, Georgia, Honduras, Kenya, Myanmar, Paraguay, Thailand & Tonga (December 2015); Cuba, El Salvador, Iraq & Guatemala (January 2016); Azerbaijan, Bolivia & Timor-Leste (February 2016); Congo, Djibouti, Lesotho & Sao Tome & P. (April 2016)
Data source: WHO/IVB Database, as of 03 May 2016 based on 101
middle income countries (MIC) as per last World Bank classification
Map production Immunization Vaccines and Biologicals (IVB),
World Health Organization
Date of slide: 3 May 2016
The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. ©WHO 2016. All rights reserved.
Introduced to date
(86 countries or 85%)
Formal commitment to introduce in 2016-2017
(15 countries or 15%)
Not applicable / not available / Not introduced / Non MICSlide8
Overview of Global birth cohort by
IPV status/tier(100% = 140.1 million births in 2016)
* Partial Introduction
Data
source: WHO/IVB Database, as of
03 May 2016
and
United Nations, Department of Economic and
Social Affairs, Population Division (2015).
World Population Prospects: The 2015 RevisionSlide9
bOPV registration status for routine immunization
Date of slide: 3 May 2016
The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. ©WHO 2016. All rights reserved.
Approval for use
(143 countries )
Review in progress
(1 country - Mexico)
Not applicable (switch area territories)
Not available/ non switch countries
Data source: WHO/IVB Database, as of 03 May 2016
based on 148 OPV user countries and 7 Territories
Map production Immunization Vaccines and Biologicals (IVB),
World Health Organization
(46 countries) + 4 countries switching from tOPV to IPV